IP Library › Patent Application 63273566
Patent Application Provisional
App. No. 63/273,566 · Confirmation No. 8153

SUBCUTANEOUS DOSING OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

Applicant: Genentech, Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2022-01-13 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2022-01-10 PA.. Power of Attorney 2 View
2022-01-10 N417 Electronic Filing System Acknowledgment Receipt 2 View
2021-11-05 APP.FILE.REC Filing Receipt 3 View
2021-11-01 CRFE Sequence Listing in Computer Readable Format, No errors found 20 View
2021-10-29 PET.COLOR A petition from Applicant to accept Color Drawings or Color Photographs 1 View
2021-10-29 TR.PROV Provisional Cover Sheet (SB16) 4 View
2021-10-29 ADS Application Data Sheet 9 View
2021-10-29 SPEC Specification 197 View
2021-10-29 CLM Claims 25 View
2021-10-29 ABST Abstract 1 View
2021-10-29 DRW.NONBW Drawings-other than black and white line drawings 14 View
2021-10-29 WFEE Fee Worksheet (SB06) 2 View
2021-10-29 N417 Electronic Filing System Acknowledgment Receipt 3 View
2021-10-29 CRFS CRF Statement that Sequence Listing text file (CRF) and paper/pdf Sequence Listing are the same 1 View
2021-10-29 SCORE Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) 1 View
2021-10-29 SEQ.TXT Sequence Listing (Text File) 1 View
2021-10-29 DRW.SUPP Drawings-black and white line and/or other drawings — View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/273,566
Filed
2021-10-29